The factors associated with distress a minimum of six months after BRCA1/2 confirmation: A systematic review. Issue 5 (3rd September 2021)

• Record Type: Journal Article
• Authors: Butler, Ellen; Collier, Sonya; Hevey, David
• Is Part Of: Journal of psychosocial oncology. Volume 39:Issue 5(2021)
• Page Start: 646
• Page End: 672
• Publication Date: 2021-09-03
• Subjects: Anxiety -- BRCA/12 -- depression -- distress -- genetic testing -- long-term; Cancer -- Psychological aspects -- Periodicals; Cancer -- Social aspects -- Periodicals; 362.196994
• DOI: 10.1080/07347332.2020.1836109
• Languages: English
• ISSNs: 0734-7332

Abstract

Abstract: Problem Identification: Many BRCA1/2 carriers experience an increase in distress after diagnosis; however, there is a need to review the longer term psychological implications of genetic confirmation and the factors associated with persistent distress. Literature Search: This article systematically reviewed the literature in line with PRISMA guidelines on distress a minimum of six months after BRCA1/2 confirmation focusing on prevalence rates and factors associated with distress. Data Evaluation and Synthesis: Fifteen studies were identified for inclusion and a narrative synthesis was conducted. Distress was associated with a range of demographic, clinical and psychological factors. A consistent finding was that although most carriers experience a reduction in distress 6–12 months after BRCA1/2 confirmation, those who experience persistent distress are more likely to have had higher distress levels at time of genetic testing. Risk reducing surgery may also play a role in reducing distress. Conclusion: The review highlights the importance of psychological assessment and the use of specific distress measures. Given the considerable challenges in synthesizing the data there is a need for further prospective studies of high methodological quality.